Seasoned Commercial Leader with Track Record in Life Sciences and Diagnostics SOUTH SAN FRANCISCO, Calif. , Aug. 01, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Jonathan Day as Vice President, Commercial Operations, Americas .
Automated Nanoscale RNA Library Preparation for Next-Generation Sequencing to Deliver Significant Savings and Workflow Efficiency for the Molecular Laboratory SOUTH SAN FRANCISCO, Calif. , Aug. 01, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools
Fluidigm Invites Researchers to the Largest Global Imaging Mass Cytometry Conference in Zurich, Switzerland SOUTH SAN FRANCISCO, Calif. , July 30, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through
Senior Biotechnology Leader with Broad Expertise in Life Science and Digital Health SOUTH SAN FRANCISCO, Calif. , July 25, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Bill W. Colston to the company’s Board of Directors.
SOUTH SAN FRANCISCO, Calif. , July 03, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that it will report second quarter 2019 financial results on Thursday,
Leading translational and clinical researchers will showcase how Fluidigm products are revolutionizing highly multiplexed cell and tissue characterization, biomarker discovery and therapeutic research development in more than 70 presentations and posters SOUTH SAN FRANCISCO, Calif.
Illuminating the diversity of immune cell phenotypes and function in the context of the tumor microenvironment, all in a single scan SOUTH SAN FRANCISCO, Calif. , June 19, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to
Powering industry-leading CyTOF technology to deliver new insights in translational and clinical research SOUTH SAN FRANCISCO, Calif. , June 17, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through
SOUTH SAN FRANCISCO, Calif. , June 04, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that Andrew Quong , PhD, has joined the company as its first-ever Chief Science Officer. Quong will lead the company’s strategy for the generation of bold scientific insights in
SOUTH SAN FRANCISCO, Calif. , May 31, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, granted an equity award effective as of May 31, 2019 , under Fluidigm’s
